BRPI0909030A2 - composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas. - Google Patents
composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.Info
- Publication number
- BRPI0909030A2 BRPI0909030A2 BRPI0909030A BRPI0909030A BRPI0909030A2 BR PI0909030 A2 BRPI0909030 A2 BR PI0909030A2 BR PI0909030 A BRPI0909030 A BR PI0909030A BR PI0909030 A BRPI0909030 A BR PI0909030A BR PI0909030 A2 BRPI0909030 A2 BR PI0909030A2
- Authority
- BR
- Brazil
- Prior art keywords
- mycophenolate
- pharmaceutical compositions
- modified release
- release pharmaceutical
- processes therefor
- Prior art date
Links
- HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 title 1
- 229940014456 mycophenolate Drugs 0.000 title 1
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN549DE2008 | 2008-03-05 | ||
| PCT/IN2009/000148 WO2009110005A2 (en) | 2008-03-05 | 2009-03-04 | Modified release pharmaceutical compositions comprising mycophenolate and processes thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0909030A2 true BRPI0909030A2 (pt) | 2018-03-13 |
Family
ID=40863399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0909030A BRPI0909030A2 (pt) | 2008-03-05 | 2009-03-04 | composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110008426A1 (pt) |
| EP (1) | EP2262483A2 (pt) |
| JP (1) | JP2011513391A (pt) |
| KR (1) | KR20100126465A (pt) |
| CN (1) | CN101969931A (pt) |
| AU (1) | AU2009220779A1 (pt) |
| BR (1) | BRPI0909030A2 (pt) |
| CA (1) | CA2717456A1 (pt) |
| EA (1) | EA201071035A1 (pt) |
| MX (1) | MX2010009704A (pt) |
| WO (1) | WO2009110005A2 (pt) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| EA015304B1 (ru) | 2006-08-03 | 2011-06-30 | Нитек Фарма Аг | Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением |
| DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
| JP5774853B2 (ja) | 2008-01-25 | 2015-09-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 医薬投薬形 |
| MX2010012039A (es) | 2008-05-09 | 2010-11-30 | Gruenenthal Gmbh | Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio. |
| ES2428938T3 (es) | 2009-07-22 | 2013-11-12 | Grünenthal GmbH | Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación |
| BR112012001547A2 (pt) | 2009-07-22 | 2016-03-08 | Gruenenthal Gmbh | forma de dosagem farmacêutica extrusada por fusão a quente |
| US20120141584A1 (en) * | 2009-08-26 | 2012-06-07 | Aptapharma, Inc. | Multilayer Minitablets |
| WO2011051967A2 (en) * | 2009-10-23 | 2011-05-05 | Alkem Laboratories Ltd | Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof |
| CA2808219C (en) | 2010-09-02 | 2019-05-14 | Gruenenthal Gmbh | Tamper resistant dosage form comprising inorganic salt |
| CN103179954A (zh) | 2010-09-02 | 2013-06-26 | 格吕伦塔尔有限公司 | 包含阴离子聚合物的抗破碎剂型 |
| CA2839123A1 (en) | 2011-07-29 | 2013-02-07 | Grunenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
| PL2736497T3 (pl) | 2011-07-29 | 2018-01-31 | Gruenenthal Gmbh | Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku |
| MX356421B (es) | 2012-02-28 | 2018-05-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico. |
| PL2838512T3 (pl) | 2012-04-18 | 2018-12-31 | Grünenthal GmbH | Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| TW201503912A (zh) * | 2013-03-19 | 2015-02-01 | Novartis Ag | 包含癌莫事（ｅｖｅｒｏｌｉｍｕｓ）之醫藥組合物 |
| MX371432B (es) | 2013-05-29 | 2020-01-30 | Gruenenthal Gmbh | Forma de dosificacion resistente al uso indebido que contiene una o mas particulas. |
| WO2014191396A1 (en) | 2013-05-29 | 2014-12-04 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
| US10624862B2 (en) | 2013-07-12 | 2020-04-21 | Grünenthal GmbH | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
| WO2015078891A1 (en) | 2013-11-26 | 2015-06-04 | Farmaceutici Formenti S.P.A. | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
| US20150320690A1 (en) | 2014-05-12 | 2015-11-12 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
| EP3148512A1 (en) | 2014-05-26 | 2017-04-05 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
| BR112017021475A2 (pt) | 2015-04-24 | 2018-07-10 | Gruenenthal Gmbh | forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente |
| WO2016185443A1 (en) | 2015-05-20 | 2016-11-24 | Novartis Ag | Pharmaceutical combination of everolimus with dactolisib |
| TWI722988B (zh) * | 2015-06-05 | 2021-04-01 | 瑩碩生技醫藥股份有限公司 | 緩釋性醫藥組合物及其製備方法 |
| AU2016319203A1 (en) | 2015-09-10 | 2018-02-22 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
| WO2017182611A1 (en) * | 2016-04-21 | 2017-10-26 | Valcuria Ab | Composition and method for pretreating cancer |
| WO2018096402A1 (en) | 2016-11-23 | 2018-05-31 | Novartis Ag | Methods of enhancing immune response with everolimus, dactolisib or both |
| CA3054817A1 (en) | 2017-03-13 | 2018-09-20 | Okava Pharmaceuticals, Inc. | Methods and compositions for delivering mycophenolic acid active agents to non-human mammals |
| CN108066322A (zh) * | 2018-02-01 | 2018-05-25 | 宁波蒙曼生物科技有限公司 | 一种吗替麦考酚酯缓释胶囊及其制备方法 |
| WO2019157516A1 (en) | 2018-02-12 | 2019-08-15 | resTORbio, Inc. | Combination therapies |
| US10835489B2 (en) | 2018-03-09 | 2020-11-17 | University Of Saskatchewan | Modified release formulations of mycophenolate mofetil |
| JP2022506007A (ja) * | 2018-09-07 | 2022-01-17 | オカヴァ ファーマシューティカルズ， インコーポレイテッド | ミコフェノール酸活性剤を非ヒト哺乳動物に送達するための方法および組成物 |
| JP6795238B1 (ja) * | 2020-06-12 | 2020-12-02 | 竹本油脂株式会社 | 合成繊維用処理剤の製造方法、合成繊維用処理剤、合成繊維、及び合成繊維の製造方法 |
| CN114569570B (zh) * | 2022-03-15 | 2023-03-24 | 浙江长典药物技术开发有限公司 | 一种吗替麦考酚酯及制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1258143B (it) * | 1992-09-11 | 1996-02-20 | Alfa Wassermann Spa | Compresse a cessione programmata contenenti naproxen |
| GB0124953D0 (en) * | 2001-10-17 | 2001-12-05 | Novartis Ag | Organic Compounds |
| US6913768B2 (en) * | 2002-09-24 | 2005-07-05 | Shire Laboratories, Inc. | Sustained release delivery of amphetamine salts |
| HRP20030324A2 (en) * | 2003-04-24 | 2005-02-28 | Pliva-Istra�iva�ki institut d.o.o. | Compounds of antiinflammatory effect |
| AR045957A1 (es) * | 2003-10-03 | 2005-11-16 | Novartis Ag | Composicion farmaceutica y combinacion |
| GB0419355D0 (en) * | 2004-08-31 | 2004-09-29 | Novartis Ag | Organic compounds |
| EP2153824A1 (en) * | 2004-09-27 | 2010-02-17 | Sigmoid Pharma Limited | Seamless multiparticulate formulations |
| US20090023805A1 (en) * | 2006-02-13 | 2009-01-22 | Anne Claire Marrast | Method of administration |
-
2009
- 2009-03-04 BR BRPI0909030A patent/BRPI0909030A2/pt not_active IP Right Cessation
- 2009-03-04 CN CN2009801078161A patent/CN101969931A/zh active Pending
- 2009-03-04 MX MX2010009704A patent/MX2010009704A/es not_active Application Discontinuation
- 2009-03-04 EA EA201071035A patent/EA201071035A1/ru unknown
- 2009-03-04 CA CA2717456A patent/CA2717456A1/en not_active Abandoned
- 2009-03-04 WO PCT/IN2009/000148 patent/WO2009110005A2/en not_active Ceased
- 2009-03-04 JP JP2010549258A patent/JP2011513391A/ja not_active Withdrawn
- 2009-03-04 EP EP09717394A patent/EP2262483A2/en not_active Withdrawn
- 2009-03-04 US US12/920,512 patent/US20110008426A1/en not_active Abandoned
- 2009-03-04 AU AU2009220779A patent/AU2009220779A1/en not_active Abandoned
- 2009-03-04 KR KR1020107022011A patent/KR20100126465A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009110005A3 (en) | 2010-10-14 |
| AU2009220779A1 (en) | 2009-09-11 |
| MX2010009704A (es) | 2010-12-20 |
| US20110008426A1 (en) | 2011-01-13 |
| EP2262483A2 (en) | 2010-12-22 |
| EA201071035A1 (ru) | 2011-04-29 |
| CN101969931A (zh) | 2011-02-09 |
| KR20100126465A (ko) | 2010-12-01 |
| CA2717456A1 (en) | 2009-09-11 |
| WO2009110005A2 (en) | 2009-09-11 |
| JP2011513391A (ja) | 2011-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0909030A2 (pt) | composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas. | |
| BRPI0918652A2 (pt) | Composições farmacêuticas e métodos de libração relacionadas. | |
| BRPI0919466A2 (pt) | composição farmacêutica para liberação modificada | |
| BRPI0910503A2 (pt) | compostos, composições farmacêuticas e respectivos usos. | |
| BRPI1010768A2 (pt) | composto, e, composição farmacêutica. | |
| BRPI0909780A2 (pt) | Composições e métodos para liberação de fármaco | |
| BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
| BR112012012108A2 (pt) | composição farmacêutica compreendendo propofol | |
| BRPI0718688A2 (pt) | Composições de baixa irritação e métodos para preparar as mesmas. | |
| BRPI0913447A2 (pt) | composição de éster, e, composição para cuidado pessoal. | |
| BRPI0818732A2 (pt) | Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais. | |
| BRPI0917358A2 (pt) | formulação farmacêutica de liberação controlada e método. | |
| BRPI0815841A2 (pt) | Métodos e composições para melhoramento de traços preferidos. | |
| BRPI1010301A2 (pt) | composição. | |
| BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
| DK2285357T3 (da) | Farmaceutisk sammensætning omfattende brivaracetam | |
| BRPI0814745A2 (pt) | Composição de produto. | |
| NL2000690A1 (nl) | Gestabiliseerde farmaceutische samenstellingen omvattende fesoterodine. | |
| BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0808032A2 (pt) | Processos para preparar hidroxipivalinaldeído e para preparar neopentil glicol. | |
| BRPI0813922A2 (pt) | composições de inibição de influenza e métodos. | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| BR112012003800A2 (pt) | composição, peptídeo, e formulação farmacêutica. | |
| BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |